Free Trial

Research Analysts Set Expectations for TriMas Q4 Earnings

TriMas logo with Industrials background

Key Points

  • BWS Financial has raised its Q4 2025 earnings per share forecast for TriMas Corporation to $0.36, reflecting a positive outlook with a "Buy" rating and a price target of $45.00.
  • TriMas reported $0.61 EPS in its latest earnings, exceeding analysts' expectations, while its quarterly revenue increased by 14.2% year-on-year to $274.76 million.
  • The company declared a quarterly dividend of $0.04 per share, contributing to an annualized dividend yield of 0.5% with a payout ratio of 17.58%.
  • MarketBeat previews top five stocks to own in September.

TriMas Corporation (NASDAQ:TRS - Free Report) - Equities research analysts at BWS Financial lifted their Q4 2025 EPS estimates for shares of TriMas in a report issued on Wednesday, July 30th. BWS Financial analyst H. Khorsand now forecasts that the industrial products company will post earnings per share of $0.36 for the quarter, up from their prior forecast of $0.33. BWS Financial currently has a "Buy" rating and a $45.00 target price on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. BWS Financial also issued estimates for TriMas' Q2 2026 earnings at $0.68 EPS, Q3 2026 earnings at $0.64 EPS and FY2026 earnings at $2.22 EPS.

Separately, Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.

Read Our Latest Stock Analysis on TriMas

TriMas Price Performance

TRS stock traded down $0.10 during midday trading on Monday, reaching $35.53. 407,480 shares of the stock were exchanged, compared to its average volume of 414,654. The stock has a market capitalization of $1.44 billion, a PE ratio of 39.04 and a beta of 0.66. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.59 and a quick ratio of 1.44. TriMas has a 52 week low of $19.33 and a 52 week high of $36.77. The company has a fifty day moving average price of $29.31 and a 200 day moving average price of $25.44.

TriMas (NASDAQ:TRS - Get Free Report) last announced its earnings results on Tuesday, July 29th. The industrial products company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.50 by $0.11. The company had revenue of $274.76 million for the quarter, compared to analysts' expectations of $251.18 million. TriMas had a net margin of 3.83% and a return on equity of 11.49%. The business's revenue for the quarter was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $0.43 earnings per share.

Institutional Trading of TriMas

A number of hedge funds have recently made changes to their positions in TRS. Sterling Capital Management LLC increased its stake in TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock worth $32,000 after purchasing an additional 1,158 shares during the period. State of Wyoming purchased a new stake in TriMas in the fourth quarter worth $50,000. KLP Kapitalforvaltning AS purchased a new position in shares of TriMas during the fourth quarter valued at approximately $202,000. Apexium Financial LP bought a new stake in TriMas in the second quarter worth $243,000. Finally, Comerica Bank lifted its stake in shares of TriMas by 214.5% in the first quarter. Comerica Bank now owns 11,119 shares of the industrial products company's stock worth $261,000 after buying an additional 7,584 shares in the last quarter. 99.42% of the stock is owned by institutional investors.

Insider Buying and Selling at TriMas

In other TriMas news, Director Shawn Sedaghat acquired 72,937 shares of the company's stock in a transaction on Thursday, May 22nd. The shares were acquired at an average cost of $26.16 per share, with a total value of $1,908,031.92. Following the completion of the acquisition, the director directly owned 1,883,758 shares in the company, valued at $49,279,109.28. This trade represents a 4.03% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Adrianne Shapira purchased 4,000 shares of TriMas stock in a transaction dated Thursday, June 5th. The stock was bought at an average price of $25.82 per share, with a total value of $103,280.00. Following the completion of the transaction, the director owned 8,476 shares of the company's stock, valued at $218,850.32. This represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 848,261 shares of company stock worth $21,645,007. Corporate insiders own 14.20% of the company's stock.

TriMas Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 12th. Shareholders of record on Tuesday, August 5th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, August 5th. TriMas's dividend payout ratio (DPR) is currently 17.58%.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Further Reading

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines